QuidelOrtho Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QDEL research report →
Companywww.quidelortho.com
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.
- CEO
- Brian J. Blaser
- IPO
- 1991
- Employees
- 6,600
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $812.15M
- P/E
- -0.67
- P/S
- 0.31
- P/B
- 0.44
- EV/EBITDA
- -6.46
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 44.96%
- Op Margin
- -36.85%
- Net Margin
- -45.57%
- ROE
- -56.31%
- ROIC
- -19.88%
Growth & Income
- Revenue
- $2.73B · -1.89%
- Net Income
- $-1,131,800,000 · 44.84%
- EPS
- $-16.69 · 45.35%
- Op Income
- $-919,200,000
- FCF YoY
- 25.96%
Performance & Tape
- 52W High
- $35.58
- 52W Low
- $9.92
- 50D MA
- $14.12
- 200D MA
- $23.93
- Beta
- 0.74
- Avg Volume
- 2.24M
Get TickerSpark's AI analysis on QDEL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Blaser Brian J. | other | 20,759 |
| May 15, 26 | Blaser Brian J. | other | 10,252 |
| May 15, 26 | Blaser Brian J. | other | 20,759 |
| Apr 26, 26 | Hanson Bryan Michael | other | 1,459 |
| Apr 26, 26 | Hanson Bryan Michael | other | 528 |
| Apr 26, 26 | Hanson Bryan Michael | other | 1,459 |
| Apr 26, 26 | McLellan Philip D. | other | 1,946 |
| Apr 26, 26 | McLellan Philip D. | other | 699 |
| Apr 26, 26 | McLellan Philip D. | other | 1,946 |
| Apr 22, 26 | McLellan Philip D. | other | 3,238 |
Our QDEL Coverage
We haven't published any research on QDEL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QDEL Report →